GRN and neoplasm: In these subgroup analyses, the negative prognostic value of negative GP88 staining on ICs was individually confirmed among patients with tumor stage 3+4, those with nodal stage N0, patients not treated with chemotherapy (CT−), as well as those with basal and luminal tumors (Table 4 and Table 5).